Back

Deep molecular phenotyping of paracardial fat unveils biological signals implicated in cardiometabolic heart failure with preserved ejection fraction

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Neuro-immune-adipose interactions in cardiovascular dysfunction and arrhythmia Heart Failure ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Alessia Mongelli

University Hospital ZǬrich, Schlieren (Switzerland)

4 More presentations in this session

Presentation thumbnail
Protein misfolding in stroke-heart syndrome: a molecular bridge between brain and heart
Ms T. Diteepeng (Schlieren, CH)
Abstract Slides Video
Presentation thumbnail
Heterogeneous sympathetic hyperinnervation and altered neurotransmitter levels in CPVT myocardium
Doctor M. O'Reilly (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Differential released proteins between epicardial and subcutaneous fat from patients with cardiovascular disease: role on its progression and semaglutide modulation
Doctor S. Eiras (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Epicardial adipose tissue-derived adipo-cytokines induce pro-oxidant and pro-remodeling responses in atrial endothelial cells: synergic inhibitory effects of SGLT2 inhibition and GLP-1R activation
Doctor W. Fakih (Strasbourg, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Neuro-immune-adipose interactions in cardiovascular dysfunction and arrhythmia
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
BET protein inhibition rewires the vascular-fat interface in cardiometabolic disease
thumbnail
Congress Presentation
The role of epicardial fat in patients with heart failure with preserved ejection fraction
thumbnail
Congress Presentation
Human epicardial adipose tissue-secreted miR-92a-3p regulates myocardial redox state via paracrine signalling: implications for cardiovascular clinical outcomes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources